Reproductive gene editing imperils universal human rights
By Marcy Darnovsky, Leah Lowthorp, and Katie Hasson,
OpenGlobalRights
| 02. 15. 2018
What do recent advances in molecular genetics have to do with human rights? Quite a lot, it turns out. And key human rights documents have recognized this for some time.
Over the past few years, new “gene editing” tools that are cheaper, easier to use, and more accurate than previous ways to change living organisms’ DNA have rapidly spread to labs around the world. Scenarios that previously seemed far-fetched or far off now confront us, including the prospect of directly controlling the genes and traits that are passed down to future children and generations. Since 2015, a half dozen research teams, in China, the UK, and the United States, have separately reported efforts to modify specific genes in human embryos. These developments have brought us to a critical juncture: human reproductive gene editing now poses a threat to the human rights of future generations.
Gene editing for human reproduction carries huge social risks. It has the potential to threaten the health and autonomy of future generations, to exacerbate existing social disparities, and to lay the basis for a new market-based...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...